Woman Receives First Corneal Transplant Made from iPS Cells

The patient’s vision has improved since the procedure, and her cornea remains clear.

Written byEmily Makowski
| 2 min read
cornea ipsc induced pluripotent stem cells corneal transplant eye disease

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, CHOREOGRAPH

A woman in Japan with a corneal disease has become the first person in the world to receive a corneal transplant made from induced pluripotent stem cells, according to a team of researchers led by ophthalmologist Kohji Nishida at Osaka University.

The cornea, a clear layer that covers the eye, contains stem cells that repair damage and maintain vision. These stem cells can be lost through injury or disease, which can then cause blurry vision and lead to blindness. As part of a clinical trial, the team performed a cornea transplant on a woman in her 40s with a corneal disease that caused her to lose these stem cells. The induced pluripotent stem cells (IPSCs) used in the transplant were taken from an adult donor, reprogrammed into an undifferentiated state, and then induced to develop into corneal stem cells.

In March, the Japanese health ministry gave ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies